| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 364-369, Copyright © 1995 by Endocrine Society
ARTICLES |
MR Letiexhe, AJ Scheen, PL Gerard, C Desaive and PJ Lefebvre
Department of Medicine, Centre Hospitalier Universitaire Sart Tilman, University of Liege, Belgium.
To study the metabolic effects of normalizing body weight, a frequently sampled iv glucose tolerance test (0.3 g/kg) was performed before [body mass index (BMI), 37.7 +/- 0.5 kg/m2] and 14 +/- 2 months after successful gastroplasty (BMI, 23.7 +/- 0.6 kg/m2) in eight obese women and, for comparison, in eight age- and weight-matched nonobese control women (BMI, 23.6 +/- 0.7 kg/m2). All subjects had normal oral glucose tolerance. The insulin secretion rate (ISR) was derived by deconvolution of plasma C-peptide levels and the insulin MCR (MCRI) by dividing the 0-180 min area under the curve (AUC) of ISR by that of plasma insulin levels (IRI). The insulin sensitivity index (SI) and the glucose effectiveness index (SG) were calculated using Bergman's minimal model. Before gastroplasty, obese subjects showed higher AUC- IRI (P < 0.001) and AUC-ISR (P < 0.02), lower MCRI (P < 0.005) and SI (P < 0.002), but similar SG values, compared to nonobese controls. After gastroplasty, the AUC-IRI dramatically decreased, due to both a reduction of AUC-ISR (from 58,252 +/- 8,437 to 36,675 +/- 4,274 pmol; P < 0.05) and an increase in MCRI (from 658 +/- 117 to 1,299 +/- 127 mL/min.m-2; P < 0.02). SI significantly rose from 4.74 +/- 0.74 to 9.15 +/- 0.96 10(-5) min-1/pmol.L (P < 0.01), whereas SG remained unchanged. All of these parameters became similar to those in nonobese controls (respectively, 32,522 +/- 3,458, 1,180 +/- 101, and 8.48 +/- 1.25; all P = NS). In conclusion, after gastroplasty-induced normalization of body weight, postobese women recover normal insulin secretion, clearance, and action on glucose metabolism.
This article has been cited by other articles:
![]() |
T. H. Inge, G. Miyano, J. Bean, M. Helmrath, A. Courcoulas, C. M. Harmon, M. K. Chen, K. Wilson, S. R. Daniels, V. F. Garcia, et al. Reversal of Type 2 Diabetes Mellitus and Improvements in Cardiovascular Risk Factors After Surgical Weight Loss in Adolescents Pediatrics, January 1, 2009; 123(1): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, F. Abbasi, J. W. Chu, T. L. McLaughlin, C. Lamendola, K. S. Polonsky, and G. M. Reaven Rosiglitazone Reduces Glucose-Stimulated Insulin Secretion Rate and Increases Insulin Clearance in Nondiabetic, Insulin-Resistant Individuals Diabetes, August 1, 2005; 54(8): 2447 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pinkney and D. Kerrigan Review: When should bariatric surgery be used in the treatment of type 2 diabetes? The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 232 - 237. [Abstract] [PDF] |
||||
![]() |
P. G. Crosignani, M. Colombo, W. Vegetti, E. Somigliana, A. Gessati, and G. Ragni Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet Hum. Reprod., September 1, 2003; 18(9): 1928 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Polyzogopoulou, F. Kalfarentzos, A. G. Vagenakis, and T. K. Alexandrides Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery Diabetes, May 1, 2003; 52(5): 1098 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Borson-Chazot, C. Harthe, F. Teboul, F. Labrousse, C. Gaume, L. Guadagnino, B. Claustrat, F. Berthezene, and P. Moulin Occurrence of Hyperhomocysteinemia 1 Year after Gastroplasty for Severe Obesity J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 541 - 545. [Abstract] [Full Text] |
||||
![]() |
D. J. Jakubowicz and J. E. Nestler 17{alpha}-Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 556 - 560. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |